http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4171317-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f76aab74ed312003383a8600e2edbd5b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 |
| filingDate | 1978-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1979-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1d21edc8a3741254822a3d5865e502 |
| publicationDate | 1979-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4171317-A |
| titleOfInvention | Selective conversion of 20-methylpregna-3,5,20(21)-triene-3,21-diol-diacetate to 3-oxo-20-methylpregna-4,20(21)-diene-21-yl-acetate |
| abstract | The present invention relates to the conversion of 20-methylpregna-3,5,20(21)-triene-3,21-diol-diacetate to 3-oxo-20-methylpregna-4,20(21)-diene-21-yl-acetate through the use of a halogenated solvent and a halogenated acid. The benefits of the present invention include a substantial increase in the production of progesterone via ozonolysis technology. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4272444-A |
| priorityDate | 1978-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.